Kabal Peptide Index

The injury peptide with loud anecdotes and mostly animal data.

BPC-157 is interesting for tendons, ligaments, gut injury, and inflammation. The signal is real enough to study seriously, but humans are still running miles ahead of the trial pipeline.

The mobility peptide people stack with BPC-157.

TB-500 is usually discussed as a systemic recovery and soft-tissue peptide. The biology is plausible, but the consumer protocol culture is much more confident than the human evidence.

The GLP-1 that made appetite optional.

Semaglutide has strong human evidence for weight loss and glycemic control. The real question is not whether it works. It is whether users preserve muscle, hormones, and sanity while using it.

The dual incretin hammer for weight loss.

Tirzepatide has very strong human data for obesity and diabetes. It is one of the rare peptide-adjacent compounds where the clinical evidence is louder than the influencer anecdotes.

A GHRH analog with real human data in a narrow lane.

Tesamorelin is one of the more legitimate growth-hormone-axis peptides because it has human data and an FDA-approved indication for HIV-associated lipodystrophy. Outside that lane, confidence drops.

The GH secretagogue people like because it feels cleaner.

Ipamorelin is popular for sleep, recovery, and body composition, but the consumer claims lean heavily on mechanism and anecdote. Treat it as exploratory, not proven.

The HPT-axis signal peptide that sounds more magical than it is.

Kisspeptin-10 is mechanistically fascinating because it sits upstream of GnRH, LH, FSH, and testosterone signaling. That does not make it a magic fertility button.

The long-acting GHRH analog that keeps IGF-1 elevated.

CJC-1295 with DAC has human data showing sustained GH and IGF-1 increases. The open question is whether chronic elevation is actually what you want outside clinical research.

The older GHRH analog with a cleaner clinical history.

Sermorelin has a more boring profile than the flashier GH peptides, which is partly why it is interesting. Human GH stimulation data exists, but optimization claims still outrun outcomes.

A potent GH secretagogue with more hormonal spillover than the “clean” options.

GHRP-2 can move growth hormone in humans. The tradeoff is that appetite, cortisol, and prolactin can enter the room too.

The old-school GH secretagogue famous for hunger.

GHRP-6 is a classic research-peptide forum compound: real GH biology, loud appetite effects, and thin modern outcome data.

The immune peptide with actual clinical literature.

Thymosin Alpha-1 has a stronger human evidence base than many trendier peptides. The catch is that evidence is mostly immune and infectious-disease context, not vague wellness optimization.

The copper peptide with skincare fame and injectable hype.

GHK-Cu has plausible skin and wound-healing biology. Topical cosmetic use is one thing. Systemic injectable claims are a much bigger leap.

The libido peptide with FDA paperwork and side effects people underplay.

Bremelanotide is not just forum mythology. It has regulatory history for sexual desire, but nausea, blood pressure, and context matter.

The tanning peptide with enough red flags to deserve its own drawer.

Melanotan II is popular because the effects are visible. That does not make it low-risk. Pigment changes, nausea, libido effects, and mole concerns are not footnotes.

The Russian anxiolytic peptide with calming anecdotes and thin Western replication.

Selank is interesting for anxiety and stress response, but the evidence base is not as clean as its fanbase makes it sound.

The focus peptide with a lot of neuroprotection talk and uneven evidence.

Semax is plausible as a neuroactive peptide, but the jump from stroke-adjacent literature to everyday productivity is a canyon.

The longevity peptide people invoke when telomeres enter the chat.

Epitalon has interesting cell and aging-adjacent literature, but practical human longevity claims are far from proven.

The sleep peptide with a name doing most of the marketing.

DSIP sounds like it should be a sleep cheat code. The evidence is much less satisfying than the acronym.

The mitochondrial peptide with exercise-mimetic ambition.

MOTS-c is one of the more interesting metabolic peptides on paper. Human intervention evidence is still early, so the hype should stay on a leash.

The antimicrobial peptide where immune biology gets complicated fast.

LL-37 is biologically real and immunologically interesting. That does not mean self-experimenting with it is straightforward or low-risk.

The “bonding hormone” that is messier than the nickname.

Oxytocin has legitimate human research, but social behavior is not a light switch. Context, dose, relationship dynamics, and baseline state matter.